Alchemab Therapeutics
4 known investors
Alchemab uses adaptive immunity and deep learning to develop antibody therapeutics for difficult-to-treat diseases by studying resilient individuals such as long-term cancer survivors.
4 known investors
Alchemab uses adaptive immunity and deep learning to develop antibody therapeutics for difficult-to-treat diseases by studying resilient individuals such as long-term cancer survivors.